| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $99.4M | +31.1% |
| Cost of Revenue | $75.5M | +20.9% |
| Gross Profit | $23.8M | +79.0% |
| R&D Expense | $14.5M | +20.4% |
| SG&A Expense | $24.1M | +5.7% |
| Operating Income | -$14.8M | +31.4% |
| Pre-tax Income | -$10.7M | +44.0% |
| Income Tax | $1.1M | +608.8% |
| Net Income | -$11.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.8M | -39.5% |
| Short-term Investments | $2.1M | +0.0% |
| Accounts Receivable | $25.6M | +33.2% |
| Inventory | $85.1M | -1.6% |
| Current Assets | $158.3M | -7.3% |
| Total Assets | $339.3M | -5.4% |
| Current Liabilities | $74.2M | -9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | -455.9% |
| Capital Expenditures | $5.8M | -44.9% |
| Investing Cash Flow | -$4.4M | -70.7% |
| Financing Cash Flow | -$536K | -106.2% |
| Free Cash Flow | -$17.9M | -152.9% |
| +35.0% |
| EPS (Basic) | -$0.27 | +35.7% |
| EPS (Diluted) | -$0.27 | +35.7% |
| Total Liabilities |
| $84.4M |
| -5.7% |
| Stockholders' Equity | $192.8M | -5.5% |